Sustained efficacy of dapagliflozin when added to metformin in type 2 diabetes inadequately controlled by metformin monotherapy

被引：0
|
作者：
Bailey, C. J. [1 ]
Gross, J. L. [2 ]
Yadav, M. [3 ]
Iqbal, N. [4 ]
Mansfield, T. A. [4 ]
List, J. F. [4 ]
机构：
[1] Aston Univ, Birmingham B4 7ET, W Midlands, England
[2] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil
[3] Bristol Myers Squibb, Bombay, Maharashtra, India
[4] Bristol Myers Squibb Co, Princeton, NJ USA
来源：
DIABETOLOGIA | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
146
引用
收藏
页码：S67 / S67
页数：1
相关论文
共 50 条
  • [31] Efficacy and Safety of Antihyperglycemic Agents Added to Metformin Monotherapy in Patients with Type 2 Diabetes
    Mearns, Elizabeth S.
    Sobieraj, Diana M.
    White, C. Michael
    Saulsberry, Whitney J.
    Doleh, Yunes
    Zaccaro, Eric
    Coleman, Craig I.
    DIABETES, 2015, 64 : A658 - A658
  • [32] Evaluating the Efficacy, Safety, and Tolerability of Combination Therapy of Dapagliflozin and Linagliptin Over Dapagliflozin and Vildagliptin in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
    Dharmalingam, Mala
    Sharma, Surendra Kumar
    Prakash, Ved
    Maiti, Animesh
    Kumar, Ritesh
    Murthy, Laxminarayanappa Sreenivasa S.
    Ramanathan, Balamurugan
    Maheshwari, Sanjiv
    Kethavath, Sunil Naik
    Ogale, Dhananjay
    Bachubhai, Prajapati Vipul Kumar
    Sonawane, Ashutosh B.
    Shah, Vaishal
    Suresh, Manjula
    Chakraborty, Sisir
    Manjunath, Krishna Kumar
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
  • [33] Efficacy and Safety of Saxagliptin Add-on to Metformin Compared with Acarbose Add-on to Metformin in Patients with Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled with Metformin Monotherapy
    Du, Jin
    Liang, Li
    Fang, Hui
    Xu, Fengmei
    Li, Wei
    Shen, Liya
    Mu, Yiming
    DIABETES, 2016, 65 : A293 - A293
  • [34] Efficacy and safety of saxagliptin and glimepiride in patients with type 2 diabetes inadequately controlled with metformin monotherapy: results from the SPECIFY study
    Gu, T.
    Zhu, L.
    Niu, Q.
    Li, C.
    Bi, Y.
    Zhu, D.
    DIABETOLOGIA, 2018, 61 : S379 - S379
  • [35] The effect of alogliptin on pulmonary function in obese patients with type 2 diabetes inadequately controlled by metformin monotherapy
    Tai, He
    Wang, Ming-Yue
    Zhao, Yue-Ping
    Li, Ling-Bing
    Dong, Qian-Yan
    Liu, Xin-Guang
    Kuang, Jin-Song
    MEDICINE, 2016, 95 (33)
  • [36] Effects of Pioglitazine (Actos®) or Sitagliptin (Januvia®) in Type 2 Diabetes Mellitus Inadequately Controlled with Metformin Monotherapy
    Handayani, Olivia
    Tandra, Hans
    DIABETES, 2010, 59 : A182 - A182
  • [37] Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone
    Charbonnel, Bernard
    Karasik, Avraham
    Liu, Ji
    Wu, Mei
    Meininger, Gary
    DIABETES CARE, 2006, 29 (12) : 2638 - 2643
  • [38] Gender Differences in Diabetes Distress Comparing Dapagliflozin plus Saxagliptin to Glimepiride When Added to Metformin in Poorly Controlled Type 2 Diabetes
    Testa, Marcia A.
    Simonson, Donald C.
    DIABETES, 2020, 69
  • [39] Efficacy and Safety of Dapagliflozin Monotherapy in Japanese Patients With Type 2 Diabetes Inadequately Controlled With Diet and Exercise
    Kaku, Kohei
    Kiyosue, Arihiro
    Inoue, Satoshi
    Ueda, Naohiko
    Tokudome, Takuto
    Yang, Jisin
    Langkilde, Anna Maria
    DIABETES, 2013, 62 : A303 - A303
  • [40] Cost-effectiveness of dapagliflozin (Forxiga®) added to metformin compared with sulfonylurea added to metformin in type 2 diabetes in the Nordic countries
    Sabale, Ugne
    Ekman, Mattias
    Granstrom, Ola
    Bergenheim, Klas
    McEwan, Phil
    PRIMARY CARE DIABETES, 2015, 9 (01) : 39 - 47
12345